Financhill
Buy
61

XERS Quote, Financials, Valuation and Earnings

Last price:
$4.79
Seasonality move :
2.12%
Day range:
$4.62 - $5.02
52-week range:
$1.84 - $6.07
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.30x
P/B ratio:
--
Volume:
1.6M
Avg. volume:
2.7M
1-year change:
144.21%
Market cap:
$784.8M
Revenue:
$203.1M
EPS (TTM):
-$0.30

Earnings Data

Next earnings date for XERS
Aug 08
2025
Most recent earnings per share
-$0.06
Missed by $0.02
(May 8/2025)
Consensus Estimate
-$0.04
(May 8/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

XERS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/08/2025 Q2 $64M -- -- -$0.03 --
05/08/2025 Q1 $57.6M $60.1M -$0.06 -$0.04 -$0.02
03/06/2025 Q4 $58.5M $60.1M -$0.03 -$0.02 -$0.01
11/08/2024 Q3 $51.4M $54.3M -$0.11 -$0.08 -$0.03
08/08/2024 Q2 $45.8M $48.1M -$0.10 -$0.09 -$0.01
05/09/2024 Q1 $41.8M $40.6M -$0.14 -$0.11 -$0.03
03/06/2024 Q4 $43.6M $44.4M -$0.09 -$0.09 -$0.00
11/09/2023 Q3 -- -- -$0.09 -$0.11 $0.02
08/08/2023 Q2 -- -- -$0.14 -$0.11 -$0.03
05/09/2023 Q1 -- -- -$0.12 -$0.15 $0.03
03/08/2023 Q4 -- -- -$0.10 -$0.15 $0.05
11/09/2022 Q3 -- -- -$0.16 -$0.16 -$0.01
08/10/2022 Q2 -- -- -$0.19 -$0.22 $0.03
05/11/2022 Q1 -- -- -$0.25 -- --
03/10/2022 Q4 -- -- -$0.42 -- --
11/10/2021 Q3 -- -- -$0.39 -- --
08/05/2021 Q2 -- -- -$0.41 -- --
05/13/2021 Q1 -- -- -$0.30 -- --
03/09/2021 Q4 -- -- -$0.41 -- --
11/09/2020 Q3 -- -- -$0.35 -- --
08/10/2020 Q2 -- -- -$0.63 -- --
05/07/2020 Q1 -- -- -$0.89 -- --
03/11/2020 Q4 -- -- -$1.23 -- --
11/07/2019 Q3 -- -- -$1.22 -- --
08/06/2019 Q2 -- -- -$1.28 -- --
05/09/2019 Q1 -- -- -$1.07 -- --
03/06/2019 Q4 -- -- -$0.98 -- --
11/07/2018 Q3 -- -- -$0.71 -- --
08/13/2018 Q2 -- -- -$3.07 -- --
03/31/2018 Q1 -- -- -$5.49 -- --
12/31/2017 Q4 -- -- -$4.22 -- --
09/30/2017 Q3 -- -- -$3.47 -- --
06/30/2017 Q2 -- -- -$2.41 -- --
03/31/2017 Q1 -- -- -$2.14 -- --

Xeris Biopharma Holdings Earnings Questions

  • How Much did Xeris Biopharma Holdings Generate in Revenue Last Quarter?

    Xeris Biopharma Holdings reported $60.1M worth of top line sales in its most recent quarter.

  • Did Xeris Biopharma Holdings Beat Earnings Last Quarter?

    Xeris Biopharma Holdings announced earnings per share of -$0.06 which represents a miss of analyst forecast a -$0.04 per share.

  • Is Xeris Biopharma Holdings Profitable?

    Xeris Biopharma Holdings reported $51.4M that represents $0.34 per share over the last quarter.

  • What is the Analyst Consensus for Xeris Biopharma Holdings EPS Next Year?

    Xeris Biopharma Holdings's earnings are forecast to decrease from -$0.37 per share to -$0.25 per share next year representing a decrease of -75.68%.

  • When is Xeris Biopharma Holdings's Earnings Date?

    Xeris Biopharma Holdings's next earnings date is August 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Uber Stock 5X?
Will Uber Stock 5X?

Uber (NYSE:UBER) has generated extremely strong returns for its investors…

How High Will Bloom Energy Stock Go?
How High Will Bloom Energy Stock Go?

Bloom Energy (NYSE:BE) has seen its shares surge by more…

Is Acuity a Good Stock to Buy Now?
Is Acuity a Good Stock to Buy Now?

Acuity Brands (NYSE:AYI) is an industrial company specializing in lighting.…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
74
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
71
NUTX alert for May 15

Nutex Health [NUTX] is up 9.76% over the past day.

Buy
81
EXEL alert for May 15

Exelixis [EXEL] is up 3.67% over the past day.

Sell
29
GLBE alert for May 15

Global E Online [GLBE] is down 3.44% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock